Pott, Janne http://orcid.org/0000-0002-5983-5331
Kheirkhah, Azin
Gadin, Jesper R.
Kleber, Marcus E.
Delgado, Graciela E.
Kirsten, Holger
Forer, Lukas
Hauck, Stefanie M.
Burkhardt, Ralph
Scharnagl, Hubert
Loeffler, Markus
März, Winfried
Thiery, Joachim
Gieger, Christian
Peters, Annette
Silveira, Angela
Hooft, Ferdinand van’t
Kronenberg, Florian
Scholz, Markus
Funding for this research was provided by:
Medical Research Council (MC_UU_0002/7)
Deutsche Forschungsgemeinschaft (209933838 - SFB-1052/4B11)
Bundesministerium für Bildung und Forschung (#01ZX1906B, SYMPATH, FKZ 01ER 0804, 01ER 0818, 01ER 0819, 01ER 0820, 01ER 0821)
Fondation Leducq (13CVD03)
Vetenskapsrådet (12660)
Hjärt-Lungfonden (201202729)
European Regional Development Fund (713–241202, 713–241202, 14505/2470, 14575/2470)
Seventh Framework Programme (AtheroRemo (201668), RiskyCAD (305739))
Horizon 2020 (848146, 101017424, IMI2 Consortium BEAt‐DKD (115974))
Österreichischer Wissenschaftsfond (W-1253 DK HOROS)
Wellcome Trust (225790/Z/22/Z)
Universität Leipzig
Article History
Received: 28 November 2023
Accepted: 13 March 2024
First Online: 26 March 2024
Declarations
:
: All six participating studies meet the ethical standards of the Declaration of Helsinki. They were approved by the respective local Ethics Committees. Study-specific registration numbers and committees are given in the Additional files. Written informed consent including agreement with genetic analyses was obtained from all participants in all studies.
: Not applicable.
: Winfried März is employed with SYNLAB Holding Deutschland GmbH. Grants and personal fees from AMGEN, BASF, Sanofi, SiemensDiagnostics, AegerionPharmaceuticals, Astrazeneca, DanoneResearch, Numares, Pfizer, Hoffmann LaRoche: personal fees from MSD, Alexion; grants from AbbottDiagnostics, all outside the submitted work. Marcus Kleber received lecture fees from Bayer and SYNLAB outside the submitted work and is employed with SYNLAB Holding Deutschland GmbH. Hubert Scharnagl received grants and personal fees from AMGEN, Sanofi, Abbott, numares, and Unilever, all outside the submitted work. Markus Scholz received funding from Pfizer Inc. for a project not related to this research. Ferdinand van ‘t Hooft received funding from Ely Lilly and Company for a project not related to this research.